Takotsubo syndrome: State-of-the-art review by an expert panel - Part 1

Andre Dias, Ivan J Núñez Gil, Francesco Santoro, John E Madias, Francesco Pelliccia, Natale Daniele Brunetti, Elena Salmoirago-Blotcher, Scott W Sharkey, Ingo Eitel, Yoshihiro J Akashi, Ibrahim El-Battrawy, Emiliana Franco, Ibrahim Akin, Milosz Jaguszewski, Dana Dawson, Vincent M Figueredo, L Christian Napp, Thomas Emil Christensen, Kathy Hebert, Itsik Ben-DorYuichi Ozaki, Héctor M García-Garcia, Alexandre H Kajita, Takashi Akasaka, Satoshi Kurisu, Amir Lerman, Ron Waksman

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Takotsubo syndrome (TTS) is an acute cardiac condition independent of epicardial coronary obstruction that mimics acute coronary syndrome and is characterized by acute heart failure with reversible ventricular motion abnormalities. This consensus paper is the result of a multinational effort aiming to summarize the current state of the art on TTS. Experts in the field provide a thorough and detailed review of this syndrome. Several novel and unique sections are emphasized in this document, including the current state of the art on genetics of takotsubo syndrome, microRNAs (miRs), racial differences, role of cardiac spectroscopy and intracoronary imaging, as well as mechanical circulatory support. In part 1 of this two-part manuscript, we discuss how TTS came to be known, several patterns and forms it can take in patients, epidemiology and pathophysiology of the syndrome, and clinical presentation.

Original languageEnglish
Pages (from-to)70-79
Number of pages10
JournalCardiovascular revascularization medicine : including molecular interventions
Volume20
Issue number1
Early online date17 Nov 2018
DOIs
Publication statusPublished - 31 Jan 2019

    Fingerprint

Keywords

  • takotsubo
  • heart failure
  • catecholamine

Cite this

Dias, A., Núñez Gil, I. J., Santoro, F., Madias, J. E., Pelliccia, F., Brunetti, N. D., ... Waksman, R. (2019). Takotsubo syndrome: State-of-the-art review by an expert panel - Part 1. Cardiovascular revascularization medicine : including molecular interventions, 20(1), 70-79. https://doi.org/10.1016/j.carrev.2018.11.015